Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedAug 9, 2023fentaNYL in 0.9% sodium chlorideLack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1061-2023Class IITerminatedAug 9, 2023HYDROmorphone in 0.9% sodium chlorideLack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1060-2023Class IITerminatedAug 9, 2023fentaNYL in 0.9% sodium chlorideLack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1059-2023Class IITerminatedAug 9, 2023HYDROmorphone in 0.9% sodium chlorideLack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1058-2023Class IITerminatedAug 9, 2023HYDROmorphone in Dextrose 5%Lack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1057-2023Class IITerminatedAug 9, 2023succinylcholineLack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1056-2023Class IITerminatedAug 9, 2023HYDROmorphone in 0.9% sodium chlorideLack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1055-2023Class IITerminatedAug 9, 2023fentaNYL in 0.9% sodium chlorideLack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1054-2023Class IITerminatedAug 9, 2023fentaNYL in 0.9% sodium chlorideLack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1053-2023Class IITerminatedAug 9, 2023HYDROmorphone added to 0.9% sodium chlorideLack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1052-2023Class IITerminatedAug 9, 2023fentaNYLLack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1051-2023Class IITerminatedAug 9, 2023fentaNYLLack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1050-2023Class IITerminatedAug 9, 2023HYDROmorphone in dextrose 5%Lack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1049-2023Class IITerminatedAug 9, 2023vecuroniumLack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1048-2023Class IITerminatedAug 9, 2023fentaNYLLack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1047-2023Class IITerminatedAug 9, 2023fentaNYLLack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1046-2023Class IITerminatedAug 9, 2023fentaNYLLack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1045-2023Class IITerminatedAug 9, 2023HYDROmorphone in 0.9% sodium chlorideLack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1044-2023Class IITerminatedAug 9, 2023fentaNYLLack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1043-2023Class IITerminatedAug 9, 2023fentaNYL in dextrose 5%Lack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1042-2023Class IITerminatedAug 9, 2023CARDIOPLEGIA SOLUTIONLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-1041-2023Class IITerminatedAug 9, 2023CARDIOPLEGIA SOLUTIONLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-1040-2023Class IITerminatedAug 9, 2023CARDIOPLEGIA SOLUTIONLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-1039-2023Class IITerminatedAug 9, 2023CARDIOPLEGIA SOLUTIONLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-1038-2023Class IITerminatedAug 9, 2023Cardioplegia SolutionLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-1037-2023Class IITerminatedAug 9, 2023CARDIOPLEGIA SOLUTIONLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-1036-2023Class IITerminatedAug 9, 2023CARDIOPLEGIA SOLUTIONLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-1035-2023Class IITerminatedAug 9, 2023CARDIOPLEGIA SOLUTIONLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-1034-2023Class IITerminatedAug 9, 2023CARDIOPLEGIA SOLUTIONLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-1033-2023Class IITerminatedAug 9, 2023CARDIOPLEGIA SOLUTIONLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-1032-2023Class IITerminatedAug 9, 2023CARDIOPLEGIA SOLUTIONLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-1031-2023Class IITerminatedAug 9, 2023CARDIOPLEGIA SOLUTION 122 mEq KLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-1030-2023Class IITerminatedAug 9, 2023CARDIOPLEGIA SOLUTIONLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-1029-2023Class IITerminatedAug 9, 2023CARDIOPLEGIA SOLUTIONLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-1028-2023Class IITerminatedAug 9, 2023CARDIOPLEGIA SOLUTIONLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-1027-2023Class IITerminatedAug 9, 2023TRANSPLANT SOLUTIONLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-1026-2023Class IITerminatedAug 9, 2023CARDIOPLEGIA SOLUTIONLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-1025-2023Class IITerminatedAug 9, 2023CARDIOPLEGIA SOLUTIONLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-1024-2023Class IITerminatedAug 9, 2023CARDIOPLEGIA SOLUTIONLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-1023-2023Class IITerminatedAug 9, 2023CARDIOPLEGIA SOLUTIONLack of assurance of sterility. Validation data for decontamination cycles is lacking.Central Admixture Pharmacy Services, Inc. · D-1022-2023